Comment: Other factors should be considered in a possible warfarin and sulfasalazine interaction [2]

Annals of Pharmacotherapy

Volumn 35, Issue 4, 2001, Pages 506-

  Sherman, J J ^a   Kovacs, M J ^a   Teefy, A M ^a  

^a UNIVERSITY OF LOUISIANA AT MONROE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESALAZINE; SALAZOSULFAPYRIDINE; WARFARIN;

ACTIVATED PROTEIN C RESISTANCE; DRUG EFFECT; LETTER; PRIORITY JOURNAL; RISK FACTOR; THROMBOEMBOLISM; THROMBOSIS;

EID: 0035091614     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.10076b     Document Type: Letter

References (4)

1. Low-dose oral contraceptives and acquired resistance to activated protein C: A randomised cross-over study
2. Resistance to activated protein C in women using oral contraceptives
3. The hypercoagulable state: Who, how, and when to test and treat
4. A method for estimating the probability of adverse drug reactions